Buprenorphine 8 mg Sublingual Tablets
- Licence status
- Active substances
- Buprenorphine hydrochloride
- Dosage Form
- Sublingual tablet
- Licence number
- PA23142/003/002
- Licence holder
- Aspire Pharma (Malta) Limited
Product documents
Licence information
- ATC code
- N02AE Oripavine derivatives, N02AE01 buprenorphine
- Route of supply
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.
- Marketing availability
- Not marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 10/09/2010
Stay updated: document advice
The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie